What the Idox deal involves
Idox (AIM: IDOX), headquartered in Woking, confirmed on 28 April that it will leave the London Stock Exchange's junior AIM market on 29 May 2026, according to a company statement reported by BusinessCloud. The acquisition, structured through a vehicle called Frankel, is led by New York-based Long Path Partners, which manages approximately $1.6 billion in assets.
Long Path is not a newcomer to Idox. The firm has held a 12% stake in the company for seven years, according to the company's disclosure. Its strategy centres on concentrated, long-term positions across public and private markets, a profile that made it a natural buyer once the board concluded that public ownership was no longer serving the business.
The offer values Idox at approximately £340 million. Once acceptances pass the 90% threshold, the company intends to re-register as a private limited company on the delisting date. Shareholders who have not tendered by that point face being locked into an illiquid private entity with no public market for their shares.
"Following the re-registration becoming effective, any remaining Idox shareholders would become minority shareholders in a privately controlled limited company and may be unable to sell their Idox shares," the company stated.
The warning is blunt, and deliberately so. Minority shareholders in a private company have limited recourse and no guaranteed exit.
Why the board chose private ownership
Idox has grown significantly since its admission to AIM in December 2000. Revenues have risen from £1.2 million at IPO to £87.6 million, according to the company's own figures. Its product lines span planning portals, elections management technology, regulatory compliance tools, and engineering document control, all serving public-sector and regulated-industry clients.
David Meaden, CEO of Idox, acknowledged late last year that "despite the performance and strategic prospects, the Idox share price has traded within a relatively narrow range for a number of years," as reported by BusinessCloud.
The board's reasoning, laid out in the offer documentation, pointed to three factors. First, the macroeconomic environment and execution risks associated with the company's growth strategy. Second, wider liquidity pressures on the UK public market. Third, the structural advantages of private ownership for a business that needs to invest through cycles.
"The Idox board considers that there are certain advantages of being a private company, in particular in the ability, more easily, to forgo short term profitability in pursuing longer term growth; and also in terms of executing material acquisitions," the board stated, according to the company's disclosure.
That final point matters. Idox operates in govtech and regulated-sector software, markets where consolidation is accelerating but where acquisition-led growth is difficult to execute under the quarterly scrutiny of public markets. Long Path has signalled plans for increased investment and, over time, growth in the overall headcount of the business, according to the board's statement.
AIM's liquidity problem for mid-cap software
Idox is not an isolated case. AIM has been losing companies at a pace that is difficult to dismiss as routine churn. According to London Stock Exchange data, the number of companies admitted to AIM has fallen steadily since its mid-2000s peak, while delistings, whether through take-privates, moves to the Main Market, or simple cancellations, have accelerated. In 2024 alone, AIM saw a net loss of more than 80 companies, according to exchange records. The trend has continued into 2025 and 2026.
Total AIM market capitalisation, which exceeded £100 billion at its height, has contracted sharply. The decline reflects both delistings and persistent undervaluation of the companies that remain.
For software businesses specifically, the problem is acute. Public-market investors have struggled to value recurring-revenue, subscription-based models at multiples comparable to those available in private transactions. Several notable UK-listed software firms have exited public markets in recent years. Micro Focus was acquired by Canada's OpenText in 2023 for approximately $6 billion. AVEVA was taken private by Schneider Electric in a deal valuing it at roughly £9.5 billion. Blue Prism was acquired by US-based SS&C Technologies for approximately £1.1 billion in 2022. In each case, the acquirer paid a significant premium to the pre-bid trading price, suggesting that public markets had been chronically underpricing these businesses.
The pattern is consistent: patient, often overseas capital identifies a UK-listed software company trading below intrinsic value, offers a premium that the board finds difficult to refuse, and takes the business private. The UK public market loses another technology company, and the cycle repeats.
Policy responses have been slow. The FCA and HM Treasury have undertaken reviews of UK listing rules, culminating in reforms to the Main Market's listing regime in 2024. But those changes were aimed primarily at attracting large-cap IPOs and did little to address the structural challenges facing AIM's mid-cap cohort: thin analyst coverage, limited institutional interest, and a dwindling pool of specialist small-cap funds.
The valuation gap
The core issue is a persistent gap between public and private valuations for software businesses. A company like Idox, with £87.6 million in revenue and a product suite embedded in critical public-sector infrastructure, would likely command a higher earnings multiple in a private transaction than AIM was willing to assign. The board's own language about a "narrow" share-price range over several years confirms that the market was not rewarding operational progress with a re-rating.
Long Path's willingness to pay £340 million, having already observed the business at close quarters for seven years as a shareholder, suggests it sees value that public-market participants either could not or would not recognise.
What operators and founders should take from this
The Idox delisting carries practical implications for anyone building or running a software business in the UK, particularly in govtech and regulated sectors.
First, AIM is no longer a reliable long-term home for mid-cap software companies. The market's liquidity has thinned to the point where share prices can remain disconnected from fundamentals for years. Boards that need to invest for the long term, whether in product development, acquisitions, or international expansion, will increasingly find that public-market pressures work against them.
Second, US private capital is actively targeting UK software businesses. Long Path is not a private equity firm running a leveraged buyout playbook. It is a concentrated, long-term investor that built conviction over seven years before making its move. Founders and boards should expect more approaches of this kind, particularly where a business has recurring revenues, embedded customer relationships, and a defensible market position.
Third, the decision to list on AIM should now be weighed against a broader set of alternatives. Private equity, growth equity, and long-term-oriented investment managers can offer capital without the overhead, disclosure burden, and valuation risk of a public listing. For businesses that do not need the signalling effect of a public listing, or that operate in markets where customers do not require it, the case for staying private has strengthened considerably.
Idox's quarter-century on AIM ends not with a crisis but with a quiet recognition that the market was no longer fit for purpose. The company's products remain critical; its revenues have grown more than seventy-fold since IPO. What changed was the environment around it. For the next generation of UK software businesses, that environment now looks markedly different from the one Idox entered in 2000.



